Preclinical dosimetry of magnetic fluid hyperthermia for bladder cancer

Tiago R. Oliveira; Paul R. Stauffer; Chen-Ting Lee; Chelsea Landon; Wiguins Etienne; Paolo F. Maccarini; Brant Inman M.D.; Mark W. Dewhirst

doi:10.1117/12.2005623

26 February 2013 Preclinical dosimetry of magnetic fluid hyperthermia for bladder cancer

Tiago R. Oliveira, Paul R. Stauffer, Chen-Ting Lee, Chelsea Landon, Wiguins Etienne, Paolo F. Maccarini, Brant Inman M.D., Mark W. Dewhirst

Author Affiliations +

Proceedings Volume 8584, Energy-based Treatment of Tissue and Assessment VII; 85840D (2013) https://doi.org/10.1117/12.2005623
Event: SPIE BiOS, 2013, San Francisco, California, United States

Abstract

Background Despite positive efficacy, thermotherapy is not widely used in clinical oncology. Difficulties associated with field penetration and controlling power deposition patterns in heterogeneous tissue have limited its use for heating deep in the body. Heat generation using iron-oxide super-paramagnetic nanoparticles excited with magnetic fields has been demonstrated to overcome some of these limitations. The objective of this preclinical study is to investigate the feasibility of treating bladder cancer with magnetic fluid hyperthermia (MFH) by analyzing the thermal dosimetry of nanoparticle heating in a rat bladder model. Methods The bladders of 25 female rats were injected with 0.4 ml of Actium Biosystems magnetite-based nanoparticles (Actium Biosystems, Boulder CO) via catheters inserted in the urethra. To assess the distribution of nanoparticles in the rat after injection we used the 7 T small animal MRI system (Bruker ClinScan, Bruker BioSpin MRI GmbH, Ettlingen, Germany). Heat treatments were performed with a small animal magnetic field applicator (Actium Biosystems, Boulder CO) with a goal of raising bladder temperature to 42°C in <10min and maintaining for 60min. Temperatures were measured throughout the rat with seven fiberoptic temperature probes (OpSens Technologies, Quebec Canada) to characterize our ability to localize heat within the bladder target. Results The MRI study confirms the effectiveness of the catheterization procedure to homogenously distribute nanoparticles throughout the bladder. Thermal dosimetry data demonstrate our ability to controllably raise temperature of rat bladder >1°C/min to a steady-state of 42°C. Conclusion Our data demonstrate that a MFH system provides well-localized heating of rat bladder with effective control of temperature in the bladder and minimal heating of surrounding tissues.

Citation Download Citation

Tiago R. Oliveira, Paul R. Stauffer, Chen-Ting Lee, Chelsea Landon, Wiguins Etienne, Paolo F. Maccarini, Brant Inman M.D., and Mark W. Dewhirst "Preclinical dosimetry of magnetic fluid hyperthermia for bladder cancer", Proc. SPIE 8584, Energy-based Treatment of Tissue and Assessment VII, 85840D (26 February 2013); https://doi.org/10.1117/12.2005623

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available